Biohaven Total Assets 2016-2022 | BHVN
Biohaven total assets from 2016 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
Biohaven Annual Total Assets
(Millions of US $) |
| 2021 |
$1,077 |
| 2020 |
$687 |
| 2019 |
$344 |
| 2018 |
$290 |
| 2017 |
$147 |
| 2016 |
$27 |
| 2015 |
$2 |
Biohaven Quarterly Total Assets
(Millions of US $) |
| 2022-09-30 |
$136 |
| 2022-06-30 |
$1,386 |
| 2022-03-31 |
$1,372 |
| 2021-12-31 |
$142 |
| 2021-09-30 |
$1,131 |
| 2021-06-30 |
$846 |
| 2021-03-31 |
$1,003 |
| 2020-12-31 |
$687 |
| 2020-09-30 |
$782 |
| 2020-06-30 |
$424 |
| 2020-03-31 |
$533 |
| 2019-12-31 |
$0 |
| 2019-09-30 |
$439 |
| 2019-06-30 |
$491 |
| 2019-03-31 |
$245 |
| 2018-12-31 |
$290 |
| 2018-09-30 |
$195 |
| 2018-06-30 |
$239 |
| 2018-03-31 |
$126 |
| 2017-12-31 |
$147 |
| 2017-09-30 |
$185 |
| 2017-06-30 |
$214 |
| 2017-03-31 |
$60 |
| 2016-12-31 |
$27 |
| 2016-09-30 |
$0 |
| 2016-06-30 |
$0 |
| 2016-03-31 |
$0 |
| 2015-12-31 |
$2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.939B |
$0.463B |
|
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
|
